April 2014 | Ophthalmology Innovation Source

WaveTec Vision Systems

WaveTec Vision® Systems, Inc. is a privately-held ophthalmic medical device company and is the proven leader in intraoperative wavefront technology. The company is focused on research, development, manufacturing, and distribution of the ORA System® with VerifEye™ (Optiwave® Refractive Analysis) used during cataract surgery. WaveTec’s ORA System’s streaming refractive information, affordable pricing model, practice support program,…

pSivida

Paul Ashton talks about the innovation within pSivida and its early stage work on proteins. pSivida has developed 3 of the 4 sustained delivery systems for the vitreous and retina that have been approved either in the US or the EU Presenter: Paul Ashton Dr. Ashton has over 25 years experience in drug delivery. He…

PowerVision

Barry Cheskin discusses PowerVision’s six month data on their pilot study and the beginning their CE mark study. Presenter: Barry Cheskin Barry Cheskin is Co-Founder, President & CEO of PowerVision. Mr. Cheskin has over 20 years of general management experience in the medical device business. View Full Profile

Panoptes Pharma

Franz Obermayr gives a short overview of Panoptes Pharma founded only last year, covering only one of their developments: C0C01 for local treatment in ophthalmology. Presenter: Franz Obermayr, PhD Dr. Franz Obermayr is Co-Founder and serves as CEO of Panoptes. Before that he was Head of Clinical Development at Nabriva, where he led the clinical efforts…

Ocular Therapeutix

Amar Sawhney gives us an update on what’s going on in Ocular Therapeutix, showing us an in depth look at their product pipeline and what we can look forward to. Presenter: Amar Sawhney, PhD Amarpreet Sawhney, Ph.D., co-founded Ocular Therapeautix in 2006, has since served as President and CEO and was elected Chairman of the…

EyeSonix

Donald Schwartz talks about TUG, which is the only ultrasound treatment designed for all open angle glaucoma. Presenter: Donald Schwartz Donald Schwartz is a comprehensive ophthalmologist in practice in Long Beach CA. He is on the clinical faculty of both USC and UC Irvine where he has taught cataract surgery and optics and refraction for…

ClarVista Medical

Paul McLean updates us on the progress of the HARMONI™ Modular IOL and its first-in-human clinical study. Presenter: Paul McLean Paul McLean is President and CEO of ClarVista Medical. ClarVista Medical is clinical stage, ophthalmic device Start-up Company focused on the development of the HARMONI modular intra-ocular lens system to optimize vision in the setting…

Clarity Medical Systems

Keith Mullowney presents Clarity’s multi-product business strategy introducing the products: RetCam & HOLOS™. Presenter: Keith Mullowney Keith L. Mullowney joined Clarity in 2005 as the Company’s Chairman of the Board and Chief Executive Officer. Mr. Mullowney has over thirty-five years of medical device industry experience in sales, marketing and general management in both large company…

Anew Optics

Anna Hayes describes Anew Optics lens design program with the specific objective of removing or managing significantly post-cataract surgery patient health issues including instability of refractive correction, capsular opacification & posterior segment events. Presenter: Anna Hayes Anna S. Hayes, CEO founded Anew Optics, Inc. and has guided the Company since its inception, managing the full…

Industry Perspectives on Ophthalmic Opportunities

Gain insight on how industry thinks about a dry eye opportunity, or a cross-linking opportunity, or a uveitis opportunity. The discussion is about no so much what they liked and didn’t like about the earlier presentations at OIS@ASCRS, but in general, what does a company have to do to get their attention, take a deeper…

The Role of OUS Clinical Studies

Malvina B. Eydelman, MD give her presentation on some of the newest directions coming out of the FDA for device studies in the US followed by a panel discussion on clinical studies in the US vs. clinical studies overseas. Moderator: Gilbert H. Kliman, MD Dr. Gil Kliman leads the medical device investment team at InterWest…

Avedro

Presenter: David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO. View Full Profile